Silo Pharma
SILO4.2501.16% ( -0.050 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Silo Pharma(SILO) the Revenue is 18.03 K (+0%);the EBIT is -1.595 M (-45.75%);the EPS is -1.8 (+47.76%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.00B45.75%
----
----
EPS
-1.802247.76%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf